March 23, 2010

Inspiring Considerations On Consulting Firms And The Anticipation Of Trends

In our modern society, pharmaceutical consulting firms are strategically positioned to help companies that are prominent in this dynamic field as they provide numerous additional elements to help the company survive through these difficult times. The majority of pharmaceutical consultants have honed their skills over many years and as industry experts, have often worked in the front line and assumed key positions in other areas before becoming consultants. Their knowledge and recommendations do not come from textbooks, but from passion, ability and a wide range of personal experiences.

In these increasingly difficult times, a pharmaceutical company must ensure that it is strategically placed and is bringing its virgin products to a tough marketplace correctly and with conviction. It is quite a journey between product manufacture and end-user and there are many layers of bureaucracy and regulation to deal with before the patient actually gets hold of the much-needed product. It is in such a taught environment that the pharmaceutical consultant can be worth his or her weight in gold.

Legislation is imminent which will change the look of the US healthcare industry (one of the world's most complex industries) after decades. Nobody is sure just how these changes will affect organisations directly involved in the business and this change is likely to unfold over a period of many months and years. This will be a period of learning for everyone and it goes without saying that the organisation that is best prepared, will capitalise the most from the opportunities ahead. Many view change as being a threatening situation, but for those who are forward thinking, they can see opportunities and will ensure that pharma consulting firms help them to delineate and take advantage accordingly.

The pharmaceutical and healthcare consulting firm should be selected on ability, its proven track record and its potential to help the company significantly. The company must have the right balance of perspective and experience to be able to make judgements and recommendations to the organisation to solve daily challenges. The pharmaceutical consultant should be a close ally to senior decision-makers within the organisation and should provide a helping hand with expert input on a timely basis.

If key management decisions appear to be built on shaky ground, the pharmaceutical consultant should always be available and ready to implement a challenge to these positions, if better tactics and an alternate approach could result in a more profitable outcome. This is not to say that the consultant should take the upper hand, but it's important that the consulting firm retains a somewhat unbiased or even a “devil's advocate” position, drawing on experience and knowledge of other situations to provide valuable intelligence.

If the pharma consulting firm is worth its salt, it will be able to look into the future and anticipate trends and bring to the attention of the organisation any emerging issues or threats likely to impact the position. Developments within the marketplace could be critical to a planned product down the road and early intervention at decision-making time can often make the difference between great profits or a failed venture. We can see that a relationship between senior executives of the company and the pharmaceutical consulting firm should be very close, with proven synergy and results.

Alan Gillies is the Director of L2L Consulting, an elite pharmaceutical consultancy firm which specialises in Strategy Development and Implementation Excellence for prestigious multi-national organisations.

Filed under Business and Management by admin